HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yuji Naito Selected Research

ecabet

7/2010Ecabet sodium promotes the healing of trinitrobenzene-sulfonic-acid-induced ulceration by enhanced restitution of intestinal epithelial cells.
3/2006Role of pancreatic trypsin in chronic esophagitis induced by gastroduodenal reflux in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yuji Naito Research Topics

Disease

70Inflammation (Inflammations)
10/2022 - 01/2002
52Neoplasms (Cancer)
05/2022 - 11/2002
46Colitis
10/2022 - 01/2002
25Stomach Neoplasms (Stomach Cancer)
08/2021 - 01/2002
23Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
07/2020 - 01/2002
22Hemorrhage
03/2022 - 01/2003
21Ischemia
03/2022 - 01/2002
19Ulcer
01/2021 - 09/2005
13Reperfusion Injury
03/2022 - 01/2002
13Infections
12/2021 - 08/2002
13Colorectal Neoplasms (Colorectal Cancer)
11/2021 - 08/2010
12Carcinogenesis
01/2019 - 01/2002
11Ulcerative Colitis
06/2022 - 12/2008
11Wounds and Injuries (Trauma)
01/2022 - 10/2005
10Body Weight (Weight, Body)
01/2022 - 01/2002
10Insulin Resistance
01/2019 - 05/2004
10Stomach Ulcer (Gastric Ulcer)
01/2018 - 09/2005
9Dysbiosis
07/2022 - 03/2016
9Neoplasm Metastasis (Metastasis)
01/2020 - 01/2003
9Type 2 Diabetes Mellitus (MODY)
01/2020 - 01/2002
9Colonic Neoplasms (Colon Cancer)
01/2018 - 01/2003
9Hyperthermia
07/2014 - 11/2002
8Crohn Disease (Crohn's Disease)
07/2022 - 04/2013
8Esophageal Neoplasms (Esophageal Cancer)
06/2022 - 08/2016
8Non-alcoholic Fatty Liver Disease
01/2022 - 09/2010
8Gastritis
01/2022 - 08/2002
8Atherosclerosis
01/2019 - 05/2002
8Hypoxia (Hypoxemia)
06/2010 - 06/2003
7Gastrointestinal Diseases (Functional Gastrointestinal Disorders)
07/2022 - 07/2005
7Pancreatic Neoplasms (Pancreatic Cancer)
10/2020 - 05/2009
6Esophageal Squamous Cell Carcinoma
05/2022 - 10/2010
6Carcinoma (Carcinomatosis)
08/2021 - 11/2002
6Metabolic Syndrome (Dysmetabolic Syndrome X)
05/2021 - 01/2009
6Esophagitis
01/2009 - 08/2004
5Irritable Bowel Syndrome (Syndrome, Irritable Bowel)
05/2022 - 12/2017
5Disseminated Intravascular Coagulation
08/2021 - 06/2003
5Enteritis
01/2019 - 01/2006
5Polyps
06/2017 - 08/2012
5Fibrosis (Cirrhosis)
09/2013 - 06/2010
4Obesity
03/2022 - 03/2008
4Adenocarcinoma
01/2022 - 02/2005

Drug/Important Bio-Agent (IBA)

34CytokinesIBA
06/2022 - 01/2002
32Proteins (Proteins, Gene)FDA Link
03/2018 - 01/2002
19Messenger RNA (mRNA)IBA
01/2022 - 01/2002
16Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2022 - 01/2002
16Sulfonic AcidsIBA
11/2021 - 03/2006
15Dextran SulfateIBA
01/2022 - 01/2002
14Carbon MonoxideIBA
03/2022 - 04/2009
14Peroxidase (Myeloperoxidase)IBA
05/2021 - 04/2004
13DNA (Deoxyribonucleic Acid)IBA
04/2016 - 11/2003
12Pharmaceutical PreparationsIBA
05/2021 - 11/2002
12Indomethacin (Indometacin)FDA LinkGeneric
02/2014 - 01/2006
12Reactive Oxygen Species (Oxygen Radicals)IBA
01/2011 - 01/2004
11LigandsIBA
05/2019 - 01/2002
11NF-kappa B (NF-kB)IBA
05/2009 - 01/2002
10Biomarkers (Surrogate Marker)IBA
05/2019 - 05/2004
10AntioxidantsIBA
12/2013 - 05/2002
9Proton Pump InhibitorsIBA
05/2022 - 01/2006
9Thiobarbituric Acid Reactive SubstancesIBA
01/2021 - 04/2004
9Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
02/2014 - 03/2008
8guar gum (guaran)IBA
05/2022 - 06/2006
8Heme Oxygenase-1IBA
03/2022 - 12/2008
8Glucose (Dextrose)FDA LinkGeneric
01/2022 - 05/2007
8Transcription Factors (Transcription Factor)IBA
01/2022 - 04/2003
8Dextrans (Dextran)FDA Link
07/2020 - 08/2004
8sodium sulfate (sodium bisulfate)FDA LinkGeneric
07/2020 - 08/2004
8PPAR gammaIBA
02/2010 - 01/2002
7Bile Acids and Salts (Bile Acids)IBA
07/2022 - 06/2011
7Therapeutic UsesIBA
01/2021 - 08/2006
7ZincIBA
07/2020 - 11/2002
7Phenobarbital (Luminal)FDA Link
07/2019 - 01/2002
7Hemoglobins (Hemoglobin)IBA
01/2017 - 05/2003
7Vitamin EFDA LinkGeneric
09/2013 - 05/2002
7Free RadicalsIBA
06/2012 - 04/2004
6Fluorouracil (Carac)FDA LinkGeneric
06/2022 - 08/2012
6Interleukin-8 (Interleukin 8)IBA
06/2022 - 01/2002
6rebamipideIBA
07/2015 - 10/2005
5Peptides (Polypeptides)IBA
10/2022 - 01/2013
5Lansoprazole (Prevacid)FDA LinkGeneric
05/2022 - 10/2004
5SolutionsIBA
01/2022 - 08/2012
5sym-trinitrobenzeneIBA
11/2021 - 08/2013
5AcidsIBA
08/2021 - 08/2002
5Carotenoids (Carotene)IBA
01/2021 - 04/2008
5polaprezinc (Z 103)IBA
04/2020 - 11/2002
5Peroxisome Proliferator-Activated Receptors (PPAR)IBA
11/2019 - 01/2010
5Insulin (Novolin)FDA Link
01/2019 - 05/2007
5oxidized low density lipoproteinIBA
01/2019 - 05/2002
5Rabeprazole (Aciphex)FDA Link
01/2017 - 09/2005
5Chemotactic FactorsIBA
09/2012 - 04/2004
5Pioglitazone (Actos)FDA Link
03/2011 - 01/2002
5Nitric Oxide (Nitrogen Monoxide)FDA Link
12/2008 - 01/2002
5Oxygen (Dioxygen)IBA
04/2007 - 04/2004
4Dietary FiberFDA Link
05/2022 - 01/2016

Therapy/Procedure

49Therapeutics
06/2022 - 01/2002
19Lasers (Laser)
01/2022 - 01/2014
18Drug Therapy (Chemotherapy)
06/2022 - 11/2007
8Enema (Enemas)
01/2021 - 03/2006
6Oral Administration
10/2016 - 11/2002
5Blood Vessel Prosthesis
01/2018 - 12/2011
4Surgical Instruments (Clip)
11/2021 - 09/2010